# Abbott Total Debt

ABT | Stock | ## USD 112.03 0.13 0.12% |

Abbott Laboratories fundamentals help investors to digest information that contributes to Abbott Laboratories' financial success or failures. It also enables traders to predict the movement of Abbott Stock. The fundamental analysis module provides a way to measure Abbott Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbott Laboratories stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Abbott | Total Debt |

**B**in 2022.

## Abbott Total Debt Analysis

Abbott Laboratories' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.## Abbott Laboratories Total Debt | ## 19.17 Billion |

Total Debt | = | Bonds | + | Notes |

## Current Abbott Laboratories Total Debt | 17.12 B |

Most of Abbott Laboratories' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

## Abbott Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Abbott Laboratories is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Total Debt. Since Abbott Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abbott Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abbott Laboratories' interrelated accounts and indicators.

**Click cells**to compare fundamentals

## Abbott Total Debt Historical Pattern

Today, most investors in Abbott Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Abbott Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Abbott Laboratories total debt as a starting point in their analysis.

Abbott Laboratories Total Debt |

Share

Timeline |

In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Compare to competition |

Based on the latest financial disclosure, Abbott Laboratories has a Total Debt of 17.12

**B**. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Devices industry. The total debt for all United States stocks is significantly lower than that of the firm.## Abbott Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.Abbott Laboratories is currently under evaluation in total debt category among related companies.

## Abbott Laboratories Current Valuation Drivers

We derive many important indicators used in calculating different scores of Abbott Laboratories from analyzing Abbott Laboratories' financial statements. These drivers represent accounts that assess Abbott Laboratories' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Abbott Laboratories' important valuation drivers and their relationship over time.

2017 | 2018 | 2019 | 2020 | 2021 | 2022 (projected) | ||

Net Income Per Employee | 4.82 K | 22.99 K | 34.46 K | 41.13 K | 62.58 K | 56.09 K | |

Revenue Per Employee | 276.67 K | 296.87 K | 298.17 K | 316.64 K | 381.19 K | 391.53 K | |

Average Assets | 72.63 B | 69.53 B | 68.12 B | 69.29 B | 73.76 B | 72.94 B | |

Earnings Before Interest Taxes and Depreciation Amortization EBITDA | 6.28 B | 7.01 B | 7.76 B | 8.87 B | 12.28 B | 10.6 B | |

Earnings Before Interest Taxes and Depreciation Amortization USD | 6.28 B | 7.01 B | 7.76 B | 8.87 B | 12.28 B | 10.6 B | |

Earnings before Tax | 2.35 B | 2.91 B | 4.08 B | 4.99 B | 8.21 B | 6.71 B | |

Average Equity | 31.66 B | 31 B | 31.59 B | 31.46 B | 34.62 B | 34.04 B | |

Enterprise Value | 112.35 B | 143.22 B | 168.61 B | 208.14 B | 257.96 B | 207.34 B | |

Free Cash Flow | 4.43 B | 4.91 B | 4.5 B | 5.72 B | 8.65 B | 7.28 B | |

Invested Capital | 40.16 B | 31.45 B | 30.8 B | 33.71 B | 34.37 B | 35.08 B | |

Invested Capital Average | 38.38 B | 32.91 B | 32.55 B | 33.39 B | 33.57 B | 33.94 B | |

Market Capitalization | 99.34 B | 127.04 B | 153.61 B | 194.06 B | 248.87 B | 197.54 B | |

Tangible Asset Value | 30.76 B | 24.98 B | 27.67 B | 34.02 B | 39.23 B | 34.16 B | |

Working Capital | 11.23 B | 5.62 B | 4.8 B | 8.53 B | 11.13 B | 9.9 B |

## Abbott Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.Environment Score | Governance Score | Social Score |

## Abbott Fundamentals

Return On Equity | 22.26 % | |||

Return On Asset | 8.56 % | |||

Profit Margin | 18.78 % | |||

Operating Margin | 22.96 % | |||

Current Valuation | 199.77 B | |||

Shares Outstanding | 1.77 B | |||

Shares Owned by Insiders | 0.73 % | |||

Shares Owned by Institutions | 75.55 % | |||

Number of Shares Shorted | 14.22 M | |||

Price to Earning | 27.66 X | |||

Price to Book | 5.73 X | |||

Price to Sales | 4.33 X | |||

Revenue | 45.55 B | |||

Gross Profit | 25.01 B | |||

EBITDA | 13.83 B | |||

Net Income | 8.53 B | |||

Cash and Equivalents | 8.16 B | |||

Cash per Share | 4.66 X | |||

Total Debt | 17.12 B | |||

Debt to Equity | 0.48 % | |||

Current Ratio | 1.85 X | |||

Book Value Per Share | 19.47 X | |||

Cash Flow from Operations | 9.96 B | |||

Short Ratio | 2.64 X | |||

Earnings Per Share | 4.03 X | |||

Price to Earnings To Growth | 1.99 X | |||

Number of Employees | 113 K | |||

Beta | 0.74 | |||

Market Capitalization | 197.13 B | |||

Total Asset | 41.25 B | |||

Retained Earnings | 26.88 B | |||

Working Capital | 4.97 B | |||

Current Asset | 14.15 B | |||

Current Liabilities | 9.19 B | |||

Z Score | 7.6 | |||

Five Year Return | 1.54 % | |||

Last Dividend Paid | 1.88 |

## About Abbott Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.Last Reported | Projected for 2022 | |

Total Debt | 18.1 B | 19.2 B |

## Abbott Laboratories Investors Sentiment

The influence of Abbott Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abbott. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Investor biases related to Abbott Laboratories' public news can be used to forecast risks associated with investment in Abbott. The trend in average sentiment can be used to explain how an investor holding Abbott can time the market purely based on public headlines and social activities around Abbott Laboratories. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.

Abbott Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbott Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abbott Laboratories' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abbott Laboratories.

## Abbott Laboratories Implied Volatility | 23.7 |

Abbott Laboratories' implied volatility exposes the market's sentiment of Abbott Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbott Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbott Laboratories stock will not fluctuate a lot when Abbott Laboratories' options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abbott Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abbott Laboratories' short interest history, or implied volatility extrapolated from Abbott Laboratories options trading.

## Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.

The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Please continue to Abbott Laboratories Piotroski F Score and Abbott Laboratories Altman Z Score analysis. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

## Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

Probability Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years | Go | |

Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings | Go | |

Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets | Go | |

Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios | Go | |

Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets | Go | |

Fundamental AnalysisView fundamental data based on most recent published financial statements | Go | |

Focused OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences | Go | |

Transaction HistoryView history of all your transactions and understand their impact on performance | Go |

Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth YOY 0.73 | Market Capitalization 196 B | Quarterly Revenue Growth YOY 0.1 | Return On Assets 0.0896 | Return On Equity 0.24 |

The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.